Re: Is viscoelastic evidence of hyperfibrinolysis the ideal indicator for tranexamic acid administration in trauma?
Division of Acute Care Surgery Department of Surgery University of Michigan Ann Arbor, MI Division of General Surgery San Francisco General Hospital University of California-San Francisco San Francisco, CA Division of Acute Care Surgery Department of Surgery University of Texas Medical School Houston, TX Section of Trauma and Critical Care Department of Surgery Oregon Health & Science University Portland, OR Division of Acute Care Surgery Department of Surgery Denver Health Medical Center University of Colorado Denver, CO.
Lena M
LM
Napolitano
Mitchell J
MJ
Cohen
Bryan A
BA
Cotton
Martin A
MA
Schreiber
Ernest E
EE
Moore
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D014148:Tranexamic Acid / Q000627:therapeutic use*; D014947:Wounds and Injuries / Q000188:drug therapy*
D000933:Antifibrinolytic Agents; D014148:Tranexamic Acid